Statement on Antiplatelet Agents and Anticoagulants in Cardiology - 2019
Carlos V Serrano1,2,3, Alexandre de M Soeiro1,3, Tatiana C A Torres Leal1
1Instituto do Coração do Hospital das Clínicas da Universidade de São Paulo, São Paulo, SP - Brazil.
No abstract available in PubMed .
More Related Videos
11:27Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging
Published on: December 4, 2016
09:19In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
Published on: May 24, 2020
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
SI Units: 2019 Redefinition
A standard set of units has been defined...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Statements of the Second Law of Thermodynamics
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Subviral Agents
